Ocular Therapeutix’ bold vision to redefine retinal disease treatment

Pathfinders in Biopharma ›

24:52 | Jul 3rd

Pravin Dugel, CEO of Ocular Therapeutix provides insights into existing treatments and future product candidates for retinal diseases, underlining the unique challenges, opportunities and innovations ...Show More